Amanda Cunningham, M.D,
Endocrinology, Diabetes & Metabolism Physician in Winston Salem, North Carolina.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,852 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Amanda Cunningham, M.D, reported a CMS MIPS final score of 94.9/100 - above the 83.1 national average - and filed 2,807 Medicare Part D claims in 2023.
- 94.9/100
- MIPS score · +12 vs avg
- 3K
- Part D claims, 2023
- 28%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Amanda Cunningham, M.D,'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
95 Top 25% higher than 75% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Amanda Cunningham, M.D, sits
This provider among endocrinology, diabetes & metabolism physician peers
Across the 2,521 endocrinology, diabetes & metabolism physician providers who report both Medicare Part D prescribing and a MIPS quality score, Amanda Cunningham, M.D, writes more Part D claims than 55% of them and scores higher on MIPS quality than 80% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one endocrinology, diabetes & metabolism physician peer from a representative sample of 60; the gold marker is Amanda Cunningham, M.D,. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Amanda Cunningham, M.D, practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Amanda Cunningham, M.D,?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in North Carolina
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among North Carolina providers
Endocrinology, Diabetes & Metabolism Physician ranks #83 among North Carolina's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the North Carolina provider total, by primary NUCC taxonomy. The highlighted bar is Endocrinology, Diabetes & Metabolism Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Amanda Cunningham, M.D,'s 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average
- MIPS Final Score
- 94.9/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) - 94.9/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Endocrinology, Diabetes & Metabolism Physician US NPIs
94.9/100 MIPS final score - 11.8 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Endocrinology, Diabetes & Metabolism Physician. Quality dim: 94.4. Cost dim: 88.6.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Amanda Cunningham, M.D, appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding M.D, credentials at MEDICAL CENTER BLVD, Winston Salem, NC, 27157, with a listed phone of (336) 713-7251. NPI 1760663579 was issued on 11/20/2007.
Medicare Part D records for calendar year 2023 show 2,807 prescription claims written by this provider, covering 480 Medicare beneficiaries and totaling roughly $144K in drug spend, split 72% brand-name and 28% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 94.9/100 for the 2023 performance year (Quality 94.4, Cost 88.6), compared with the national average of 83.1.
Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1760663579 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | M.D, |
| Gender | Female |
| NPI Issued | 11/20/2007 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Amanda Cunningham, M.D,'s current license status, disciplinary history, and board certifications with the North Carolina Medical Board in North Carolina before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1760663579 is the unique 10-digit identifier CMS uses to link Cunningham across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Amanda Cunningham, M.D,. Source: openpaymentsdata.cms.gov.
Total received
$248
Largest payer
Amgen Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
72% brand-name claims vs 28% generic, on 2,807 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 4,266
- Total Day Supply
- 126,945
- Brand vs Generic
- 72% brand / 28% generic
- Brand Drug Cost
- $134K
- Generic Drug Cost
- $10K
Patient Demographics
- Average Patient Age
- 71.6 years
- Avg HCC Risk Score
- 1.19
- Gender Split
- 84% female / 16% male
- Age Distribution
- <65: 74, 65-74: 212, 75-84: 158, 85+: 36
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Amanda Cunningham, M.D, prescribes most
Top Medicare Part D drugs by claim count, 2023
- Synthroid
Synthroid
1,907 claims
- Methimazole 475
Methimazole
475 claims
- Levothyroxine Sodium 167
Levothyroxine Sodium
167 claims
- Metformin Hcl 74
Metformin Hcl
74 claims
- Vitamin D2 52
Vitamin D2
52 claims
- Liothyronine Sodium 50
Liothyronine Sodium
50 claims
- Calcitriol 44
Calcitriol
44 claims
| Drug | Claims |
|---|---|
| Synthroid Levothyroxine Sodium | 1,907 |
| Methimazole | 475 |
| Levothyroxine Sodium | 167 |
| Metformin Hcl | 74 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 52 |
| Liothyronine Sodium | 50 |
| Calcitriol | 44 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Endocrinology, Diabetes & Metabolism Physician Overview
How Amanda Cunningham, M.D, fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
Amanda Cunningham, M.D,'s 2,807 claims are above the specialty average of 2,639.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in North Carolina
Other clinicians with the same primary specialty enrolled in North Carolina, drawn from the same CMS NPPES roster as Cunningham.
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the North Carolina medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Endocrinology, Diabetes & Metabolism Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore North Carolina
Frequently Asked Questions
What is Amanda Cunningham, M.D,'s specialty? ▼
How much does Amanda Cunningham, M.D, prescribe under Medicare Part D? ▼
What is Amanda Cunningham, M.D,'s Medicare quality score? ▼
Where is Amanda Cunningham, M.D, located? ▼
What is Amanda Cunningham, M.D,'s NPI number? ▼
Does Amanda Cunningham, M.D, prescribe more brand-name or generic drugs? ▼
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
What drugs does Amanda Cunningham, M.D, prescribe most often? ▼
Does Amanda Cunningham, M.D, accept Medicare? ▼
How can I verify Amanda Cunningham, M.D,'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology